Cargando…

Choice of antithrombotics in acute coronary syndrome – A balance of efficacy versus safety

Detalles Bibliográficos
Autores principales:	Kaul, Upendra, Mohan, Jagdish C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990739/ https://www.ncbi.nlm.nih.gov/pubmed/27543463 http://dx.doi.org/10.1016/j.ihj.2015.11.029

Ejemplares similares

Management of Antithrombotics before Endoscopy-Balancing the Risks
por: Kim, Joon Sung, et al.
Publicado: (2022)

Short- and long-term follow-up of antithrombotic management patterns in patients hospitalized with acute coronary syndrome: Indian subgroup of EPICOR Asia study
por: Sawhney, J.P.S., et al.
Publicado: (2019)

New Antithrombotic Drugs in Acute Coronary Syndrome
por: Zwart, Bastiaan, et al.
Publicado: (2020)

Efficacy and Safety of Antithrombotic Therapy With Oral Anticoagulants in Real-World Elderly Patients With Acute Coronary Syndrome and Atrial Fibrillation
por: Wu, Yangxun, et al.
Publicado: (2022)

Evidenced-Based Antithrombotic Therapy for Acute Coronary Syndromes
por: James, Stefan
Publicado: (2013)

New Antithrombotics for Secondary Prevention of Acute Coronary Syndrome
por: Goto, Shinya, et al.
Publicado: (2014)

Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes
por: Bonanad, Clara, et al.
Publicado: (2022)

Adding to the evidence or to the confusion: dual antithrombotic therapy in chronic coronary syndrome and atrial fibrillation
por: Kany, Shinwan, et al.
Publicado: (2021)

Development of New Antithrombotic Regimens for Patients with Acute Coronary Syndrome
por: George, Sudhakar, et al.
Publicado: (2019)

Efficacy and safety of an antithrombotic regimen for atrial fibrillation patients with acute coronary syndrome or those undergoing percutaneous coronary intervention: a meta-analysis
por: Guo, Wenqin, et al.
Publicado: (2020)

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
por: Bor, Wilbert, et al.
Publicado: (2020)

Current Perspectives on Antithrombotic Therapy for the Treatment of Acute Coronary Syndrome
por: Towashiraporn, Korakoth, et al.
Publicado: (2022)

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
por: Pham, Son V, et al.
Publicado: (2010)

Effect of antithrombotic stewardship on the efficacy and safety of antithrombotic therapy during and after hospitalization
por: Dreijer, Albert R., et al.
Publicado: (2020)

Variability of Antithrombotic Dosing Among Veterans Presenting With Acute Coronary Syndrome
por: Plomondon, Mary E., et al.
Publicado: (2015)

Risk Stratification after an Acute Coronary Syndrome: Significance of Antithrombotic Therapy
por: Brazhnik, Victoria A., et al.
Publicado: (2021)

Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention
por: Parikh, Shailja V, et al.
Publicado: (2009)

Effect and safety of antithrombotic therapies for secondary prevention after acute coronary syndrome: a network meta-analysis
por: Mo, Fanrui, et al.
Publicado: (2018)

Antithrombotic Therapy in Patients with Acute Coronary Syndrome in the Intermountain Heart Collaborative Study
por: Knight, Stacey, et al.
Publicado: (2015)

Prognostic implications of thyroid hormone alterations in acute coronary syndrome–A systematic review
por: Arambam, Priyadarshini, et al.
Publicado: (2021)

Monitoring of Antithrombotic Therapy
por: Yamazaki, Masako
Publicado: (2020)

Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
por: De Luca, Leonardo, et al.
Publicado: (2022)

Antithrombotic Therapy After Acute Coronary Syndromes or Percutaneous Coronary Interventions in East Asian Populations
por: Kwon, Osung, et al.
Publicado: (2022)

Safety and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: A meta-analysis
por: Moustafa, Abdelmoniem, et al.
Publicado: (2020)

Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial
por: Fudim, Marat, et al.
Publicado: (2021)

Multimodal analgesia or balanced analgesia: the better choice?
por: Shim, Jae Hang
Publicado: (2020)

Pharmacy Benefit Spending Poised to Increase for Antithrombotic Drug Therapy--Prasugrel Versus Clopidogrel
por: Curtiss, Frederic R.
Publicado: (2009)

Comparative Safety and Efficacy of Eight Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Liang, Bo, et al.
Publicado: (2022)

Antithrombotic Strategy for Patients with Acute Coronary Syndrome: A Perspective from East Asia
por: Numasawa, Yohei, et al.
Publicado: (2020)

2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome
por: Tan, Jack Wei Chieh, et al.
Publicado: (2021)

Efficacy and Safety of Long‐Term Antithrombotic Strategies in Patients With Chronic Coronary Syndrome: A Network Meta‐analysis of Randomized Controlled Trials
por: Zhu, Houyong, et al.
Publicado: (2021)

Balancing Choices to Recover From the COVID-19 Pandemic
por: Parrish, James M., et al.
Publicado: (2020)

Optimal Oral Antithrombotic Regimes for Patients with Acute Coronary Syndrome: A Network Meta-Analysis
por: Ye, Yicong, et al.
Publicado: (2014)

Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients
por: Husted, Steen
Publicado: (2015)

Antithrombotic treatment tailoring and risk score evaluation in elderly patients diagnosed with an acute coronary syndrome
por: Mischie, Alexandru Nicolae, et al.
Publicado: (2017)

Long-term follow-up of antithrombotic management patterns in patients with acute coronary syndrome in China
por: Han, Xiao-Ning, et al.
Publicado: (2020)

Long-term residual cardiovascular risk after acute coronary syndrome: antithrombotic treatment options
por: Chan Pin Yin, D. R. P. P., et al.
Publicado: (2021)

Beginning the Journey to Find Optimal Antithrombotic Regimens for Korean Patients with Atrial Fibrillation after Percutaneous Coronary Intervention
por: Kim, Sung Soo, et al.
Publicado: (2021)

Reversal of Antithrombotic Therapy: Is it Necessary and Sufficient?
por: Becker, Richard C.
Publicado: (2017)

Impact of triple antithrombotic therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention in real-world practice
por: Yan, Yan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o1qpgtin11e57d822j3gpefrhp